Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21

収録刊行物

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ